David Kelly Net Worth

The estimated Net Worth of David M Kelly is at least $1.06 Million dollars as of 8 November 2021. Mr. Kelly owns over 18 units of Mesa Laboratories stock worth over $313,034 and over the last 21 years he sold MLAB stock worth over $573,421. In addition, he makes $174,871 as Independent Director at Mesa Laboratories.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Kelly MLAB stock SEC Form 4 insiders trading

David has made over 23 trades of the Mesa Laboratories stock since 2010, according to the Form 4 filled with the SEC. Most recently he exercised 18 units of MLAB stock worth $1,053 on 8 November 2021.

The largest trade he's ever made was exercising 3,000 units of Mesa Laboratories stock on 9 February 2015 worth over $82,320. On average, David trades about 133 units every 29 days since 2003. As of 8 November 2021 he still owns at least 2,618 units of Mesa Laboratories stock.

You can see the complete history of Mr. Kelly stock trades at the bottom of the page.

David Kelly biography

David M. Kelly serves as Independent Director of the Company. Mr. Kelly currently serves as a member of the Board of Directors of Federated Investors, Inc. (NYSE: FII), Mestek (OTC: MCCK), and a privately held company. In 1995, Mr. Kelly joined Matthews International Corporation, where he served as Chairman of the Board, Chief Executive Officer and President until his retirement in 2007. From 1972 to 1995, Mr. Kelly was with Carrier Corporation and held a variety of executive positions, in the United States and in Asia, in marketing, finance, manufacturing and operations, including President of North America operations. He received a Bachelor of Science degree in Physics from Boston College in 1964, a Master’s degree in Molecular Biophysics from Yale in 1966, and a Masters of Business Administration from Harvard Business School in 1968.

What is the salary of David Kelly?

As the Independent Director of Mesa Laboratories, the total compensation of David Kelly at Mesa Laboratories is $174,871. There are 9 executives at Mesa Laboratories getting paid more, with Gary Owens having the highest compensation of $3,485,970.

How old is David Kelly?

David Kelly is 78, he's been the Independent Director of Mesa Laboratories since 2010. There are no older and 14 younger executives at Mesa Laboratories.

What's David Kelly's mailing address?

David's mailing address filed with the SEC is , , , , .

Insiders trading at Mesa Laboratories

Over the last 21 years, insiders at Mesa Laboratories have traded over $50,273,983 worth of Mesa Laboratories stock and bought 209,660 units worth $5,099,819 . The most active insiders traders include Mark Christopher Capone, R Tony Tripeny und John James Sullivan. On average, Mesa Laboratories executives and independent directors trade stock every 20 days with the average trade being worth of $430,930. The most recent stock trade was executed by Gary M Owens on 6 September 2024, trading 3,301 units of MLAB stock currently worth $394,701.

What does Mesa Laboratories do?

mesa laboratories, inc., develops, manufactures and markets high-quality process validation, monitoring and calibration instruments and consumables worldwide. mesa offers quality data loggers for monitoring temperature, humidity, and pressure and biological indicators (bis) for medical device and pharmaceutical manufacturing sterilization monitoring. the datatrace data loggers and mesa bis are available to monitor and validate applications including steam and eo sterilization, autoclave validation, incubators, heat tunnels and more. mesa’s bi offering also includes bis for industrial use, hydrogen peroxide (h2o2), chlorine dioxide and more. the phoenix meter is a point-of-use dialysate qc meter used prior to each procedure. the 90xl meter is the industry standard for calibration of dialysis machines in the field. also available are industry leading nist-traceable calibration solutions. mesa also offers cap torque testers which are durable, reliable and computerized cap torque analyzers

Complete history of Mr. Kelly stock trades at Matthews International und Mesa Laboratories

Mesa Laboratories executives and stock owners

Mesa Laboratories executives and other stock owners filed with the SEC include:

• Gary Owens,
  President, Chief Executive Officer, Director
• John Sakys,
  Chief Financial Officer, Executive Vice President, Chief Accounting Officer, Corporate Secretary
• Greg DiNoia,
  Senior Vice President - Commercial Operations
• Gary M. Owens,
  CEO, Pres & Director
• Brian Archbold,
  Senior Vice President - Continuous Improvement
• Brian David Archbold,
  Sr. VP of Continuous Improvement
• John V. Sakys,
  CFO & Chief Accounting Officer
• Gregory T. DiNoia,
  Sr. VP of Commercial Operations
• John Sullivan,
  Chairman of the Board
• John Schmieder,
  Independent Director
• David Kelly,
  Independent Director
• Evan Guillemin,
  Independent Director
• Jennifer Alltoft,
  Independent Director
• Shannon Hall,
  Director
• Peter M. Dansky,
  Pres of Clinical Genomics
• Garrett Krushefski,
  Sr. VP of Operations
• Bryan T. Leo,
  Sr. VP of Operations
• Gina Hinman Trulli,
  VP of HR
• Elizabeth Karpinski Vonne,
  VP of Legal, Gen. Counsel & Sec.
• Robert Bradley,
  Sr. Director of Operations
• Michael T Brooks,
  Director
• H Stuart Campbell,
  Director
• Ventures, Llc Seg,
  Director
• Luke R Schmieder,
  President CEO Treasurer
• Paul D Duke,
  Director
• Michael Tranmer,
  Executive Vice President
• Glenn E Adriance,
  VP Sales and Marketing
• Steven W Peterson,
  VP Finance, CFO, Secretary
• Robert V Dwyer,
  Director
• David Brian Perez,
  Director
• Mark Christopher Capone,
  Director
• Shiraz Shabanali Ladiwala,
  Director
• Laboratories Inc /Co/ Mesa,
  Director
• R Tony Tripeny,
  Director